Corteva Inc.
CTVA | NYSE
$79.57
-$0.96 (-1.19%)
Sep 21, 2026, 11:31 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 17.81B | 17.89B | 17.4B | 17.47B | 17.18B | 16.83B | 16.91B | 16.64B | 16.9B | 16.83B | 17.23B | 17.34B | 17.53B | 17.74B | 17.46B | 17.11B | 16.7B | 16.08B | 15.66B | 15.38B | 14.88B | 14.44B |
Cost of Revenue | 9.5B | 9.52B | 9.33B | 9.41B | 9.34B | 9.32B | 9.53B | 9.4B | 9.48B | 9.7B | 9.92B | 10.06B | 10.3B | 10.48B | 10.44B | 10.16B | 9.84B | 9.52B | 9.22B | 9.1B | 8.84B | 8.66B |
Gross Profit | 8.32B | 8.37B | 8.07B | 8.06B | 7.84B | 7.51B | 7.38B | 7.24B | 7.42B | 7.14B | 7.31B | 7.28B | 7.23B | 7.26B | 7.02B | 6.95B | 6.87B | 6.55B | 6.44B | 6.28B | 6.04B | 5.78B |
Operating Income | 2.99B | 2.91B | 2.58B | 2.68B | 2.52B | 2.3B | 2.17B | 2.01B | 2.21B | 1.93B | 2.11B | 1.99B | 2.01B | 2.11B | 1.93B | 1.83B | 1.74B | 1.45B | 1.32B | 1.26B | 1.12B | 917M |
Interest Income | 73M | 138M | 136M | 131M | 135M | 129M | 132M | 223M | 249M | 278M | 283M | 202M | 179M | 149M | 124M | 94M | 77M | 71M | 77M | 76M | 68M | 59M |
Pretax Income | 1.58B | 1.76B | 1.69B | 2.31B | 2.04B | 1.58B | 1.28B | 864M | 1.05B | 799M | 1.09B | 1.21B | 1.26B | 1.5B | 1.43B | 1.87B | 2.28B | 2.25B | 2.35B | 2.03B | 1.52B | 1.06B |
Net Income | 1.01B | 1.16B | 1.09B | 1.61B | 1.4B | 1.14B | 907M | 695M | 898M | 559M | 735M | 933M | 923M | 1.18B | 1.15B | 1.36B | 1.72B | 1.72B | 1.76B | 1.64B | 1.22B | 1.01B |
Selling & General & Admin | 3.63B | 3.62B | 3.49B | 3.26B | 3.24B | 3.14B | 3.12B | 3.14B | 3.13B | 3.16B | 3.18B | 3.3B | 3.25B | 3.2B | 3.17B | 3.22B | 3.23B | 3.21B | 3.21B | 3.13B | 3.05B | 3.02B |
Research & Development | 1.49B | 1.48B | 1.47B | 1.43B | 1.42B | 1.41B | 1.4B | 1.39B | 1.38B | 1.35B | 1.34B | 1.32B | 1.3B | 1.26B | 1.22B | 1.19B | 1.18B | 1.17B | 1.19B | 1.18B | 1.16B | 1.14B |
Other Expenses | 206M | 367M | 529M | 693M | 657M | 670M | 685M | 696M | 700M | 700M | 683M | 674M | 678M | 683M | 702M | 715M | 717M | 718M | 722M | 724M | 706M | 702M |
Operating Expenses | 5.33B | 5.47B | 5.5B | 5.38B | 5.32B | 5.21B | 5.21B | 5.23B | 5.22B | 5.21B | 5.2B | 5.29B | 5.23B | 5.14B | 5.09B | 5.12B | 5.12B | 5.1B | 5.12B | 5.03B | 4.92B | 4.86B |
Interest Expense | 175M | 180M | 180M | 194M | 214M | 228M | 233M | 235M | 227M | 243M | 233M | 207M | 167M | 101M | 79M | 51M | 41M | 32M | 30M | 32M | 35M | 42M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.82B | 14.98B | 14.83B | 14.79B | 14.66B | 14.54B | 14.74B | 14.63B | 14.7B | 14.91B | 15.12B | 15.35B | 15.53B | 15.63B | 15.53B | 15.28B | 14.96B | 14.63B | 14.34B | 14.13B | 13.76B | 13.52B |
Income Tax Expense | 486M | 500M | 484M | 615M | 563M | 423M | 412M | 182M | 167M | 89M | 152M | 82M | 137M | 258M | 210M | 462M | 508M | 467M | 524M | 265M | 176M | -30M |
Shares Outstanding (Basic) | 670.4M | 672.5M | 673.17M | 678.7M | 681.7M | 684.9M | 687.3M | 691.1M | 695.9M | 700.4M | 704M | 708.4M | 710.8M | 712.9M | 714.7M | 718.7M | 723M | 727M | 729.2M | 733.8M | 737.3M | 743.4M |
Shares Outstanding (Diluted) | 671.6M | 673.6M | 673.17M | 678.7M | 683.1M | 686.6M | 687.3M | 691.1M | 698.1M | 702.8M | 704M | 708.4M | 713.7M | 716.2M | 714.7M | 718.7M | 726.7M | 730.9M | 735.1M | 739.5M | 743.3M | 749.6M |
EPS (Basic) | 1.51 | 1.71 | 1.59 | 2.35 | 2.06 | 1.64 | 1.29 | 0.99 | 1.30 | 0.79 | 1.02 | 1.30 | 1.29 | 1.63 | 1.58 | 1.88 | 2.38 | 2.36 | 2.39 | 2.23 | 1.66 | 1.35 |
EPS (Diluted) | 1.51 | 1.70 | 1.58 | 2.34 | 2.05 | 1.64 | 1.29 | 0.99 | 1.30 | 0.79 | 1.02 | 1.30 | 1.29 | 1.62 | 1.57 | 1.87 | 2.37 | 2.35 | 2.37 | 2.20 | 1.64 | 1.34 |
EBITDA | 3.24B | 3.15B | 3.07B | 3.7B | 3.46B | 3.02B | 2.74B | 2.34B | 2.52B | 2.27B | 2.54B | 2.62B | 2.64B | 2.81B | 2.73B | 3.16B | 3.55B | 3.53B | 3.62B | 3.3B | 2.76B | 2.3B |
EBIT | 2B | 1.94B | 1.87B | 2.5B | 2.26B | 1.81B | 1.51B | 1.1B | 1.28B | 1.04B | 1.33B | 1.42B | 1.43B | 1.61B | 1.51B | 1.93B | 2.32B | 2.29B | 2.38B | 2.06B | 1.55B | 1.1B |
Depreciation & Amortization | 1.24B | 1.2B | 1.2B | 1.2B | 1.21B | 1.22B | 1.23B | 1.24B | 1.24B | 1.23B | 1.21B | 1.2B | 1.21B | 1.2B | 1.22B | 1.24B | 1.24B | 1.25B | 1.24B | 1.24B | 1.21B | 1.2B |
Add to Watchlist
Select watchlists to add or remove CTVA